Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
agitation
AMPA receptor antibodies
amphiphysin antibodies
anti IgLON5
ataxia
ataxia, cerebellar
ataxia, truncal
ataxic gait
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autoimmune encephalopathy
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
behavioral disorder, acute
carcinoma
catatonia
cerebellar degeneration
cerebellitis, autoimmune
cerebral cortex
children
chorea
choreoathetosis
cognition
collapsin response mediator protein 5 IgG
complications
confusion
constipation
dementia
diagnostic criteria
diarrhea
differential diagnosis
diplopia
DPPX
DPPX, antibodies
DPPX, antibodies, encephalitis
dysarthria
dysdiadochokinesia
dyskinesia
dyskinesia, facial
dysphagia
dystonia
electroencephalogram, abnormalities of
encephalitis
encephalitis, autoimmune
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
eye movement, disorders of
faciobrachial dystonic seizure
fever
gait disorder
gamma amino butyric acid receptor antibody
gastrointestinal disease, neurologic complications
gender
glycine receptor antibodies
hallucination
headache
herpes simplex encephalitis
hyperekplexia
hyperesthesia
hypersomnia
hyponatremia
immunologic disease
immunotherapy
insomnia
intellectual deficit
intellectual deterioration
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
memory
memory, defect of recent
memory, impairment of
mental status, abnormal
mesial temporal lobe
monoclonal antibodies
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, FLAIR
MRI, negative
myelitis, transverse, recurrent
myoclonus
neurexin-3 alpha antibodies
neurologic disease, diagnoses of
neuronal cell surface antigen
NMDA antagonists
nystagmus
personality change
pleocytosis of cerebrospinal fluid
precipitating factors
prognosis
progressive neurologic disorder
psychiatric problems in neurologic disorders
psychosis
recurrent
remote effect of cancer on the nervous system
review article
rituximab
screening
seizure
seizure, adult onset
seizure, unknown origin
serologic testing
serologic testing, false negative
sleep pathology and physiology
speech disorder
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
titubation
treatment of neurologic disorder
tremor
walking, difficulty with
weight loss
white matter disease
white matter disease, subcortical
wide based gait
workup
Showing articles 850 to 900 of 2250 << Previous Next >>

Concepts and Controversies in Nonketotic Hyperglycemia-Induced Hemichorea: Further Evidence from Susceptibility-Weighted MR imaging
J Magn Reson Imaging 29:699-703, Cherian, A.,et al, 2009

Spinal Cord Involvement in Balos Concentric Sclerosis
J Neurol Sci 279:114-117, Kreft, K.L.,et al, 2009

Multiple Bilateral Non-Hemorrhagic Cerebral Infarctions Associated with Microscopic Polyangiitis
Clin Neurol Neurosurg 111:904-906, Ku, B. & Shin, H., 2009

Microscopic Polyangiitis Presenting with Capsular Warning Syndrome and Subsequent Stroke
J Neurol Sci 277:174-175, Tang, C.,et al, 2009

Non-Infectious Endocarditis in a Patient with cANCA-associated Small Vessel Vasculitis
Rheumatology 48:592-594, Horino, T.,et al, 2009

Intracranial Calcifications
Applied Radiology 48-60, Makariou,E. & Patsalides,A., 2009

Frequent Hemorrhagic Lesions in Cerebral Toxoplasmosis in AIDS Patients
J Neuroimaging 19:169-173, Bhagavati, S. & Choe, J., 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Acute Disseminated Encephalomyelitis Following Vacicnation Against Human Papilloma Virus
Neurol 72:2132-2133, Wildemann,B.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009

Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009

MRI Findings Associated With Acute Liver Failure
Neurol 72:2130-2131, Fridman,V.,et al, 2009

Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Neuromyelitis Optica and Concentric Rings of Bal� in the Brainstem
Arch Neurol 66:274-275, Graber,J.J.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Posterior Reversible Encephalopathy Syndrome in Neuromyelitis Optica Spectrum Disorders
Neurol 72:712-717, Maga�a,S.M.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Detection of Human Herpesvirus-6 in Cerebrospinal Fluid of Patients with Encephalitis
Ann Neurol 65:257-267,235, Yao,K.,et al, 2009

Diagnosis and New Treatment in Muscle Channelopathies
JNNP 80:360-365, Meola,G.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Fatal Case of Deer Tick Virus Encephalitis
NEJM 360:2099-2107, Tavakoli,N.P.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Clinicopath Conf., Eastern Equine Encephalitis
NEJM 359:294-303, Case 22-2008, 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

MR Imaging Findings in Hepatic Encephalopathy
AJNR 29:1612-1621, Rovira,A.,et al, 2008

MR Imaging of Familial Creutzfeldt-Jakob Disease: A Blinded and Controlled Study
AJNR 29:1638-1643, Fulbright,R.K.,et al, 2008

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study
Lancet 372:1463-1472, Kappos,L.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Pseudo-Subarachnoid Hemorrhage Found in Patients With Postresuscitation Encephalopathy: Characteristics of CT Findings and Clinical Importance
AJNR 29:1544-1549, Yuzawa,H.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

Poststreptococcal Dystonia With Bilateral Striatal Enlargement: MR Imaging and Spectroscopic Findings
AJNR 29:1276-1278, Kendi,A.T.K.,et al., 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008



Showing articles 850 to 900 of 2250 << Previous Next >>